Pasta maker Barilla funds cell therapy research for coronavirus
The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to U.S. non-profit association “The Cure Alliance” to fund research on a COVID-19 therapy based on stem cells, the group said on Monday.
The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the U.S. Food and Drug Administration, Barilla said.
A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.
The money adds to a previous 2 million euro ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company’s home country.
Reuters
Related news
According to two-thirds of Hungarians, lifestyle changes are necessary due to climate change
According to a new survey conducted by the European Investment…
Read more >The benefits of ESG are slowly emerging
The number of people interested in the new ESG regulation,…
Read more >Employers who don’t offer hybrid work may lose two-thirds of talent
Companies that don’t offer hybrid work opportunities may be missing…
Read more >Related news
Using 30% less materials would be a solution to the climate crisis
The circular economy is a global imperative: it transcends geographical…
Read more >The Hégető Honorka Awards were presented for the twentieth time
This year, the Honorka Hégető Awards were presented for the…
Read more >The World Science Forum starts in Budapest today
The World Science Forum (WSF) begins today in Budapest, with…
Read more >